Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.",""
Zanamivir is a sialic acid-analogue neuraminidase inhibitor with antiviral activity. Administered into the respiratory tract by aerosol inhalation, zanamivir selectively binds to and inhibits influenza A and B virus neuraminidase-mediated cleavage of sial
Coenen, S. (2013);"2008-2009 Influenza Season Week 32 ending August 15, 2009"
We normally respond within 8 hours.
This page contains information about Zanamivir Cas # 139110-80-8 and its API Standards.
Zanamivir Zanamivir Worldwide Suppliers of Zanamivir https://www.clearsynth.com/en/CSO30822.html API Standards Clearsynth 139110-80-8
Regular price: $100 In stock
Product rating: 9 Zanamivir based on 20 ratings
Keywords: API Standards 4-Guanidino-Neu5c2en CS-O-30822 Zanamivir Zanamivir 139110-80-8 332.31 C12H20N4O7
Internal standard, Internal standard Zanamivir, HPLC-MS method validation, HPLC-MS method validation Zanamivir, LC-MS-MS method validation, LC-MS-MS method validation Zanamivir, Deuterated internal standard, Deuterated internal standard Zanamivir, Deuterated Zanamivir, Deuterium labeled Zanamivir, Quantitative bioanalytical methods, Quantitative bioanalytical methods Zanamivir, Blood samples Zanamivir, Blood concentrations, Heavy drugs, Analysis, Analysis Zanamivir, Clinical diagnostic, Clinical diagnostic Zanamivir, Dosing Zanamivir, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945